Pfizer (PFE)
Company | Ticker | Sector | Industry | Quality | PAR |
---|---|---|---|---|
Pfizer | PFE | Healthcare | Drug Manufacturers - General | 93 | 15.2% |
Current Price ( 3/18 4:00PM EDT) | $27.72 | |||
CAPS Rating (Rate this stock on CAPS) | ||||
Expected Income Statement | ||||
Current Sales | 53,268.5 | |||
Sales Growth Forecast | 4.9% | |||
Net Profit Margin | 30.3% | |||
Projected Shares Outstanding | 5,600.00 | |||
EPS - Five year Forecast | $3.66 | |||
Average P/E Ratio | 13.0 | |||
Projected Average Price | $47.60 | |||
Price Appreciation (Annualized) | 11.4% | |||
Annual Dividend Yield | 3.8% | |||
Projected Annual Return | 15.2% | |||
Quality | ||||
Financial Strength | 80 | 20.0 | ||
EPS Stability | 77 | 19.2 | ||
Industry Sales Growth Rate | 4.0% | 15.3 | ||
Industry Net Profit Margin | 19.3% | 19.6 | ||
Calculated Quality Rating | 74.1 | |||
Fool CAPS | ||||
Total Players
5617
Outperforms
591
Underperforms
All-Stars (947)
871
Outperforms (92%)
76
Underperforms
|
||||
Fundamental Data Updated: 12/29/2023 |